The latest London South East Webinar takes place on July 6. Come and hear CEO’s from Orosur Mining, Caledonia Mining, Glantus Holdings and Tekcapital speak. Please register here

Less Ads, More Data, More Tools Register for FREE
Games developer tinyBuild seeks to boost £500 million market cap by becoming a media company
Games developer tinyBuild seeks to boost £500 million market cap by becoming a media companyView Video
Samarkand Group update the market at the London South East Aquis Special webinar
Samarkand Group update the market at the London South East Aquis Special webinarView Video

Latest Share Chat

UPDATE 1-AstraZeneca weighs seeking full U.S. approval for COVID shot - WSJ

Fri, 7th May 2021 23:23

(Adds background related to AstraZeneca vaccine)

May 7 (Reuters) - AstraZeneca Plc may skip asking
the U.S. Food and Drug Administration for emergency-use
authorization for its COVID-19 vaccine and instead pursue the
more time-intensive application for a full-fledged license to
sell the shot, the Wall Street Journal reported on Friday.

Such a step would further delay any rollout of the British
drugmaker's shots in the United States, according to the report
https://on.wsj.com/3eWvrry, which cited people familiar with the
matter.

The company did not immediately respond to a request for
comment late on Friday.

Last week, AstraZeneca said it was working as fast as
possible to compile data on its COVID-19 vaccine to apply for
U.S. approval, but that the dataset was very big. The company
said it planned to apply for U.S. approval in the coming weeks.

The White House said late in April that the United States
would start to share up to 60 million doses of AstraZeneca's
coronavirus vaccine with other countries over the next few
weeks.

AstraZeneca's COVID-19 shot, developed by Oxford University,
has resulted in reports of rare blood clots with low platelet
levels that occur more commonly in younger adults. Some
countries have advised the shot be given only to older people.

(Reporting by Kanishka Singh in Bengaluru
Editing by Chris Reese and Sonya Hepinstall)

Related Shares

More News

IN BRIEF: DeepMatter partners with universities on automated precision

IN BRIEF: DeepMatter partners with universities on automated precision

17 Jun 21 19:14

Redx Pharma gets milestone sum from AstraZeneca for therapy progress

Redx Pharma gets milestone sum from AstraZeneca for therapy progress

17 Jun 21 14:07

Thursday broker round-up

(Sharecast News) - Pets At Home: Liberum upgrades to buy with a target price of 510p.

17 Jun 21 13:49

IP Group investee Apollo Therapeutics completes USD145 million raise

IP Group investee Apollo Therapeutics completes USD145 million raise

17 Jun 21 09:48

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.